. PG I2 stimulating plasma activity measured by bioassay and expressed as PG I2-like activity. AP=angina pectoris; AMI=acute myocardial infarction; OMI+AP=old myocardial infarction associated with angina pectoris. The activity was compared between control and patient groups. *p<0.05, **p<0.01, ***p<0.001. Fig.2 (right). Plasma activity in individual patients after 5 min of incubation.
in the control and patient groups, but the activity in AMI was smaller than that of the control (Fig.4) .
Correlation of plasma activity to blood compositions High density lipoprotein (HDL) accelerates and low density lipoprotein.
(LDL) inhibits PG I2 synthesis. However, the plasma activity measured by bioassay had no correlation to HDL, LDL or the atherogenic index (total cholesterol-HDL/HDL) (Fig.5) . Albumin inhibits synthesis and breakdown of PG I2, however, the plasma activity had no correlation to albumin concentration.
Lowering pH accelerates and elevating pH inhibits breakdown of PG I2 however, the activity had no correlation to plasma pH.
Time-course changes in plasma activity in AMI The time course changes in plasma activity were examined in 3 patients with AMI who had received no medication before blood sampling which might have affected the arachidonic cascade . The activity showed a tendency to increase in the second day in 1 but not in the other 2 patients . Fig.3 (left) . PG I2 stimulating plasma activity measured by RIA. VAP=variant angina pectoris; AP=stable angina pectoris. Fig.4 (right) . PG I2 stimulating activity in deproteinized plasma in the same control and patient groups as those in Fig.3 . 
